Is Novavax Delaying Its COVID Vaccine EUA Filings Yet Again?
Novavax(NASDAQ:NVAX) has found hitting target dates for regulatory filings is easier said than done. The company delayed its planned submissions for Emergency Use Authorization for COVID-19 vaccine NVX-CoV2373 earlier this year. In this Motley Fool Live…
